Ardent Health Faces $43M Revenue Loss Due to Accounting Changes
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5h ago
0mins
Source: Globenewswire
- Financial Loss Disclosure: Ardent Health's financial results announced on November 12, 2025, revealed a $43 million revenue reduction due to accounting changes and a $54 million increase in professional liability reserves, indicating a severe deterioration in the company's financial health.
- Stock Price Plunge Impact: Following this news, Ardent's stock price plummeted by $4.75, or 33.81%, closing at $9.30 per share on November 13, 2025, reflecting strong market concerns regarding the company's financial transparency.
- Legal Action Risks: Faruq & Faruqi LLP is investigating potential claims against Ardent and reminds investors to apply for lead plaintiff status in a federal securities class action by March 9, 2026, which could impose further legal and financial pressures on the company.
- Investor Rights Protection: The law firm encourages all investors who purchased Ardent securities between July 18, 2024, and November 12, 2025, to contact them to discuss their legal rights, demonstrating a commitment to protecting investor interests.
Analyst Views on ARDT
Wall Street analysts forecast ARDT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARDT is 13.96 USD with a low forecast of 10.00 USD and a high forecast of 17.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
13 Analyst Rating
8 Buy
4 Hold
1 Sell
Moderate Buy
Current: 9.210
Low
10.00
Averages
13.96
High
17.00
Current: 9.210
Low
10.00
Averages
13.96
High
17.00
About ARDT
Ardent Health, Inc., formerly Ardent Health Partners, Inc., is a provider of healthcare in mid-sized urban communities across the United States. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and approximately 280 sites of care with over 1,800 affiliated providers across six states. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. In addition to its 30 acute care hospitals, it operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers (ASCs), urgent care centers, free-standing emergency departments, and diagnostic imaging centers. It operates a consumer-centric healthcare platform focused on creating relationships with its patients across multiple care settings.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
